Test Price
2,800 AED✅ Home Collection Available
MID2 Gene X‑Linked Intellectual Disability Type 101 – NGS Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑certified laboratory processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post‑test clinical interpretation with a genetic specialist.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Core Metrics
Test Price: 2 800 AED
Turnaround Time: 3–4 Weeks
Sample Type: Peripheral Whole Blood / FTA Card
Methodology: Next‑Generation Sequencing (NGS)
Test Overview & Methodology
This test uses Next‑Generation Sequencing (NGS) to detect pathogenic variants in the MID2 gene, responsible for X‑linked intellectual disability type 101. The assay targets single‑nucleotide variants, small insertions, and deletions with a diagnostic sensitivity exceeding 99.9%. Results are interpreted in the context of family history, clinical phenotype, and standardised variant classification guidelines.
| Feature | Our Test (NGS – MID2) | Chromosomal Microarray (CMA) |
|---|---|---|
| Precision | 99.9% sensitivity for MID2 single‑nucleotide variants & indels | Detects large deletions/duplications, misses point mutations |
| Methodology | Next‑Generation Sequencing (NGS) | Array‑based comparative genomic hybridisation |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Target | MID2 gene (X‑linked intellectual disability) | Broad chromosomal imbalances |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I recognise the profound uncertainty families face when exploring a genetic cause for intellectual disability. This NGS test delivers precise molecular data, yet it must always be integrated with a thorough clinical evaluation, detailed family history, and formal genetic counselling. No medical decision should ever rest on a genetic result alone.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue or adjust any prescribed medication without direct consultation with your treating physician. Genetic test results should complement, not replace, ongoing clinical management.
Exclusion Criteria & Emergency Red Flags
- Individuals unable to give informed consent (e.g., acute psychiatric instability).
- Minors under 18 years without legal guardian consent, in line with UAE Federal Law regulations.
- If the patient experiences acute suicidal ideation, sudden loss of consciousness, or rapid neurological worsening, seek immediate emergency medical care – do not wait for test results.
Patient FAQ & Clinical Guidance
1. What is the MID2 gene test and who should consider it?
The MID2 NGS test diagnoses X‑linked intellectual disability type 101, primarily indicated for males presenting with developmental delay and a maternal family history of learning difficulties. Carrier females may also benefit from targeted testing to inform reproductive planning.
2. How is the sample taken and is home collection available?
A standard peripheral blood draw or FTA card collection is performed at your home, office, or an accredited collection centre by ISO‑certified phlebotomists. VIP Mobile Phlebotomy is available daily from 8 AM to 11 PM with temperature‑controlled cold‑chain logistics.
3. How long do results take and how will I understand them?
Results are delivered within 3–4 weeks from sample receipt. Every patient receives a scheduled telephonic consultation with a Consultant Medical Genetics specialist to interpret findings, discuss implications, and guide next steps.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance Framework
DNA Labs UAE operates under DHA Facility License Number 1143 and adheres to the highest standards of data protection and clinical safety. Patient information is processed in strict accordance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, storage, and transfer of personal health data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital health infrastructure.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – defining clinical safety and patient consent obligations.
All genetic data is encrypted, access‑controlled, and retained only for the lawful period required by UAE health regulations.
Clinical & Logistical Metadata
| Test Name | MID2 Gene X‑Linked Intellectual Disability Type 101 – NGS Test |
| Price (AED) | 2 800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or FTA Card |
| Methodology Used | Next‑Generation Sequencing (NGS) – Targeted Gene Panel |
| ICD-10-CM Code | F70 (Mild intellectual disabilities) |
| LOINC Code | 51966-0 (DNA mutations identified in gene(s) by sequencing) |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians